Cullen/Frost Bankers’s Immunomedics Inc IMMU Stock Holding History

Cullen/Frost Bankers’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,577	Closed	-$21K	–	1110
2019 Q3	$21K	Buy	+1,577	New	+$23.2K	﹤0.01%	715

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Cullen/Frost Bankers's IMMU Position: Q4 2019 in Review

Cullen/Frost Bankers sold out of Immunomedics Inc (IMMU) in Q4 2019, closing a stake of 1,577 shares — an estimated $21K sold.

Cullen/Frost Bankers first reported a position in IMMU in Q3 2019 and held it in 1 quarter. The position peaked at $21K in Q3 2019. 245 funds tracked by Wall St. Rank hold IMMU as of Q4 2019.

Cullen/Frost Bankers reported no remaining Immunomedics Inc position as of Q4 2019 after selling out during the quarter.
Cullen/Frost Bankers sold 1,577 Immunomedics Inc shares in Q4 2019, an estimated $21K.
Cullen/Frost Bankers first reported a position in Immunomedics Inc in Q3 2019 and held it in 1 quarter.
Cullen/Frost Bankers's Immunomedics Inc position peaked at $21K in Q3 2019.
245 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2019.

Based on Cullen/Frost Bankers's 13F filing for Q4 2019, filed 6 Feb 2020.